ARCHIVES

P-32 Ingestion At NCI Attracts Attention; Similar Cases Seen At Labs In The Past

This article is from The Cancer Letter archive.

Vol. 21 No. 42 | November 3, 1995

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Working Group Offers 21 Recommendations to improve efficiency of trials.

February 25, 2005

FASEB Urges Congress To Fund Stem Cell Research.

July 27, 2001

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

NCI To Lose 19% of Workforce Over Six Years, Broder Says

November 4, 1994

In Brief: Deadline June 1 For Cancer Research Institute Grants; Chabner To Present Karnofsky Lecture

May 3, 1985

FDA Holds Up Another IND; Rauscher, FDA Commissioner Hold “Excellent” Meeting

March 19, 1976